Rare Disease News and Research

RSS

Insilico and Bora Pharmaceuticals forge strategic AI-driven drug discovery alliance

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced a multi-target strategic alliance with Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing.

14 Jul 2026

AI errors shaped doctors’ judgments despite contradictory evidence

Two experiments involving 223 self-reported physicians found that incorrect AI patient classifications strongly influenced treatment decisions and effectiveness judgments. Even when patient outcomes contradicted the AI, participants struggled to revise their conclusions and, in one experiment, judged a completely ineffective treatment as beneficial.

13 Jul 2026

Physicians often trust incorrect AI treatment recommendations, study finds

In experiments in which physicians made decisions about treating hypothetical patients, the physicians tended to trust incorrect advice presented as being generated by artificial intelligence (AI), even after given the opportunity to notice that patient recovery data contradicted the recommendations.

9 Jul 2026

Purdue University accelerates rare disease drug discovery with the WELLJET dispenser stacker

Automated liquid handling with the WELLJET dispenser at Purdue accelerates drug discovery for neglected diseases, increasing throughput and reproducibility.

From INTEGRA Biosciences 9 Jul 2026

n6 launches icon16™, expanding AutoNorm™ adaptive amplification to lower-throughput NGS workflows

In 2024, n6 introduced icon96™, redefining expectations for PCR amplification in NGS library preparation.

From n6 7 Jul 2026

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

Research led by Professor Hodson-Tole combines ultrasound and AI to improve motor neuron disease diagnosis, reducing reliance on invasive procedures.

6 Jul 2026

Rare genetic condition offers new insights into human aging process

Scientists have discovered a rare genetic condition which causes people to age at a much faster rate, offering fresh insights into the aging process.

30 Jun 2026

Pioneering gene therapy for rare immune disorder shows promise in early pre-clinical studies

The development of a pioneering gene therapy to treat a devastating, rare immune disorder led by UCL scientists is set to move into its next phase following promising early pre-clinical studies.

27 Jun 2026

Discovery of karyoptosis opens new therapeutic targets for Alzheimer's and frontotemporal dementia

Markers of a new mechanism for cell death, called karyoptosis, have been found in brains of patients with Alzheimer's disease and frontotemporal dementia (FTD).

25 Jun 2026

Open source tool automates data reanalysis to detect rare diseases

A newly developed open-source tool designed for rigorous reanalysis of genomic data is highly effective at detecting new rare disease diagnoses.

24 Jun 2026

Gene therapy shows promise against deadly childhood liver disease

A new gene therapy has been used to successfully treat a deadly childhood liver disease using mice that model this disease by researchers at UCL and Great Ormond Street Hospital.

23 Jun 2026

Gene therapy successfully treats deadly childhood liver disease in mice

A new gene therapy has been used to successfully treat a deadly childhood liver disease using mice that model this disease by researchers at UCL and Great Ormond Street Hospital.

19 Jun 2026

New DNA test improves diagnosis of rare genetic disorders

A new test provides a much more complete picture of DNA than current standard diagnostics and leads to a diagnosis more often.

13 Jun 2026

New genetic driver found for rare small intestinal cancers

A signaling system known as the Wnt pathway plays a central role in how cells in the intestine grow, divide, and renew themselves.

12 Jun 2026

Study identifies an important driver of inflammatory bowel disease

Researchers at the Nuffield Department of Medicine, University of Oxford, together with Newcastle University's Translational and Clinical Research Institute and the Department of Immunology at Cambridge University Hospitals NHS Foundation Trust, have identified an important driver of inflammatory bowel disease (IBD).

10 Jun 2026

Grant fuels research into SYNGAP1-linked behavioral abnormalities

CURE SYNGAP1 501(c)(3) is pleased to announce a $130,000 grant to Dr. Helen Willsey and Dr. David Kastner at the University of California, San Francisco (UCSF).

5 Jun 2026

Hidden junk DNA could play decisive role in cancer

Many repetitive regions of the genome have been considered "junk DNA" because the technologies available did not allow them to be studied at sufficient resolution.

5 Jun 2026

Genetic testing identifies cause of pancreatic agenesis in infants

The DNA changes responsible for a rare genetic condition causing babies to be born without a pancreas can now be identified in almost all affected children through genetic testing.

1 Jun 2026

New computational tool uses plain language for genetic diagnosis

A new computational tool called MARRVEL-MCP helps researchers move toward genetic diagnoses more efficiently by analyzing and interpreting vast amounts of genetic and biological information using everyday language.

21 May 2026

Phase two clinical trial demonstrates dramatic mobility gains in children with severe fibrous dysplasia

Fibrous dysplasia is a rare skeletal disorder in which normal bone is gradually replaced by weak fibro-osseous tissue, leading to fractures, pain, deformities, and severe mobility impairment. In many patients, diseased bone tissue produces excessive amounts of fibroblast growth factor-23 (FGF23), a hormone that causes phosphate loss through the kidneys.

21 May 2026